Revisiting entinostat as an immune-potentiating adjuvant.
作者信息
McCaw Tyler R, Randall Troy D, Arend Rebecca C
机构信息
Tyler R. McCaw: Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
出版信息
Oncotarget. 2018 Dec 18;9(99):37278-37279. doi: 10.18632/oncotarget.26453.
Abstract
摘要
相似文献
1
Revisiting entinostat as an immune-potentiating adjuvant.重新审视恩替诺司他作为一种免疫增强佐剂的作用。
Oncotarget. 2018 Dec 18;9(99):37278-37279. doi: 10.18632/oncotarget.26453.
2
The antitumor effects of entinostat in ovarian cancer require adaptive immunity.恩替诺特在卵巢癌中的抗肿瘤作用需要适应性免疫。
Cancer. 2018 Dec 15;124(24):4657-4666. doi: 10.1002/cncr.31761. Epub 2018 Nov 13.
3
Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma.恩替诺特中和髓源性抑制细胞，并增强 PD-1 抑制在肺和肾细胞癌小鼠模型中的抗肿瘤作用。
Clin Cancer Res. 2017 Sep 1;23(17):5187-5201. doi: 10.1158/1078-0432.CCR-17-0741. Epub 2017 Jul 11.
4
The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat.局部复发或转移性雌激素受体阳性乳腺癌中表观遗传治疗与免疫的相互作用：ENCORE 301的相关分析，一项来曲唑联合或不联合恩替诺特的随机、安慰剂对照II期试验
Oncoimmunology. 2016 Aug 31;5(11):e1219008. doi: 10.1080/2162402X.2016.1219008. eCollection 2016.
5
Entinostat for the treatment of breast cancer.恩替诺特用于治疗乳腺癌。
Expert Opin Investig Drugs. 2017 Aug;26(8):965-971. doi: 10.1080/13543784.2017.1353077. Epub 2017 Jul 24.
6
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.Jun 缺失促进了腔乳腺癌中 Myc 信号对组蛋白去乙酰化酶抑制剂恩替诺特的耐药性。
Genome Med. 2018 Nov 30;10(1):86. doi: 10.1186/s13073-018-0597-3.
7
Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.恩替诺特是一种新型组蛋白去乙酰化酶抑制剂，对B细胞淋巴瘤具有活性，并能增强利妥昔单抗和化疗药物的抗肿瘤活性。
Br J Haematol. 2015 May;169(4):506-19. doi: 10.1111/bjh.13318. Epub 2015 Feb 23.
8
Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.I 类组蛋白去乙酰化酶（HDAC）抑制优于泛 HDAC 抑制，可调节高级别浆液性卵巢癌细胞系中顺铂的效力。
Int J Mol Sci. 2019 Jun 22;20(12):3052. doi: 10.3390/ijms20123052.
9
The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines.组蛋白去乙酰化酶抑制剂恩替诺特增强聚合物介导的癌细胞系转基因表达。
Biotechnol Bioeng. 2016 Jun;113(6):1345-1356. doi: 10.1002/bit.25898. Epub 2015 Dec 30.
10
Entinostat augments NK cell functions via epigenetic upregulation of IFIT1-STING-STAT4 pathway.恩替诺特通过IFIT1-STING-STAT4通路的表观遗传上调增强自然杀伤细胞功能。
Oncotarget. 2020 May 19;11(20):1799-1815. doi: 10.18632/oncotarget.27546.
本文引用的文献
1
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.TGFβ 通过促使 T 细胞排除而减弱肿瘤对 PD-L1 阻断的反应。
Nature. 2018 Feb 22;554(7693):544-548. doi: 10.1038/nature25501. Epub 2018 Feb 14.
2
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.用于指导癌症治疗中免疫检查点阻断的机制驱动生物标志物。
Nat Rev Cancer. 2016 May;16(5):275-87. doi: 10.1038/nrc.2016.36. Epub 2016 Apr 15.
3
Immune checkpoint blockade: a common denominator approach to cancer therapy.免疫检查点阻断：癌症治疗的一种通用方法。
Cancer Cell. 2015 Apr 13;27(4):450-61. doi: 10.1016/j.ccell.2015.03.001. Epub 2015 Apr 6.
4
Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence.顺铂诱导的抗肿瘤免疫调节：临床前和临床证据综述
Clin Cancer Res. 2014 Nov 1;20(21):5384-91. doi: 10.1158/1078-0432.CCR-14-1298. Epub 2014 Sep 9.
5
Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.通过对 1525 例患者样本的荟萃分析预测晚期卵巢癌的风险。
J Natl Cancer Inst. 2014 Apr 3;106(5):dju048. doi: 10.1093/jnci/dju048.
6
Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.组织转谷氨酰胺酶将 TGF-β、上皮到间充质转化和卵巢癌中的干细胞表型联系在一起。
Oncogene. 2012 May 17;31(20):2521-34. doi: 10.1038/onc.2011.429. Epub 2011 Oct 3.
7
Lysine acetylation targets protein complexes and co-regulates major cellular functions.赖氨酸乙酰化作用于蛋白质复合物，并共同调节主要的细胞功能。
Science. 2009 Aug 14;325(5942):834-40. doi: 10.1126/science.1175371. Epub 2009 Jul 16.
Zotero 插件